ليست عنوان مقالات لاتين Canadian health-care spending soars Candidate Positioning and Entry in a Political Competition

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Canadian health-care spending soars

2

Canadian hopes for low-cost drugs dashed

3

Canadian hospitals call for restrictions on single-use devices

4

Canadian House Dust Study: Population-based concentrations, loads and loading rates of arsenic, cadmium, chromium, copper, nickel, lead, and zinc inside urban homes Original Research Article

5

Canadian hydrogen safety program

6

Canadian hypertension society guidelines for ambulatory blood pressure monitoring

7

Canadian infection-control experts push for health reform

8

Canadian insights: The challenges of an integrated environmental assessment framework

9

Canadian institutes fund new initiatives in health research

10

Canadian Intellectual Property Office: backfile conversion project: 1992–1996

11

Canadian judge allows marijuana as therapy

12

Canadian kimberlites: Geological characteristics relevant to emplacement

13

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

14

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

15

Canadian Medical Association champions private medicine

16

Canadian Medical Associationʹ president guilty of misconduct

17

Canadian men need a healthier lifestyle

18

Canadian mercury inventories: the missing pieces

19

Canadian military malarial prophylaxis under scr utiny

20

Canadian Milling Practice : Edited by B. Damjanovic and J.R. Goode xi + 292 pages 22x 28.7 cm, hard cover, published by Canadian Institute of Mining, Metallurgy, and Petroleum, Montreal 2000. Price $80 ($65 for members, $45 for students) + postage ($10 Ca

21

Canadian MRC encourages private sector partnership

22

Canadian multicenter pilot trial of haploidentical donor transplantation

23

Canadian National Air Pollution Surveillance (NAPS) PM2.5 speciation program: Methodology and PM2.5 chemical composition for the years 2003–2008

24

Canadian National Breast Screening Study

25

Canadian national power quality survey: frequency and duration of voltage sags and surges at industrial sites

26

Canadian naturopathic practitioners: holistic and scientific world views

27

Canadian NOx/VOC Science Assessment: science and policy linkages

28

Canadian Occupational Performance Measure Supported by Talking Mats: An Evaluation of the Clinical Utility

29

Canadian officials criticised over soldiersʹ care

30

Canadian officials watch SARS-like mystery bug

31

Canadian Opinions on Refractive Surgery and Approaches to Presbyopia Correction

32

Canadian panel calls for review of drug-trial confidentiality agreements

33

Canadian Parliament finally agrees human reproduction research act

34

Canadian pastoral: promotional images of British colonization in Lower Canadaʹs Eastern Townships during the 1830s

35

Canadian patent profile: Some explorations in patent statistics Original Research Article

36

Canadian petrochemical plants blamed for gender imbalance

37

Canadian practitionersʹ perception of research work investigating the cost premiums, long-term costs and health and productivity benefits of green buildings

38

Canadian programme reverses high anaemia incidence

39

Canadian prohibition against immigrants with disabilities is challenged

40

Canadian province opens door to two-tier health service

41

Canadian provincial health ministers press for change

42

Canadian R&D abroad management practices

43

Canadian Red Cross fires secretary-general

44

Canadian Red Cross found negligent

45

Canadian regulation of private security in an international perspective

46

Canadian regulatory approach to ensuring the implementation of effective ageing management programs for nuclear power plants

47

Canadian report quantifies cost of medical errors

48

Canadian researchers awarded record damages

49

Canadian researchers respond to CMAJ crisis

50

Canadian respirologistʹs murder trial appeal quashed

51

Canadian retailing strategy: Challenges and change : William A. Crowe and Mark E. Siemonsen Nelson Canada, Scarborough, Ontario: (1996) 444 pp. ISBN 0 17 6055770

52

Canadian scientists urge government to develop antibiotic plan

53

Canadian scientists vindicated over whistleblowing

54

Canadian settlement guarantees world medical isotope supply

55

Canadian soldiers and doctors face torture allegations

56

Canadian space environment program and international living with a star Original Research Article

57

Canadian spending on prescription drugs is increasing

58

Canadian Steinernematid (Nematoda) Isolates and Their Infectivity, under Cold Conditions, to Greater Wax Moth (Galleria mellonella) Larvae

59

Canadian suppliers of mining goods and services: links between Canadian mining companies and selected sectors of the Canadian economy: Minerals and Metals Sector; Natural Resources Canada, 2000, xvi + 58pp., free upon request, ISBN 0-662-84954-7, softcove

60

Canadian tourist information and the UK: plans and perceptions

61

Canadian universities go shopping for research scientists

62

Canadian university publishes new rules to protect scientists

63

Canadian waters provide critical foraging habitat for leatherback sea turtles Original Research Article

64

Canadians allow targeted transfusion

65

Canadians are fighting fit, says government report

66

Canadians finally fill regulatory void with stem-cell bill

67

Canadians in Alabama: a perceptual study of dialect acquisition in adults

68

Canadians inquire into drug licensing

69

Canadians propose overhaul of research-ethics guidelines

70

Canadians still stung by WHOʹs SARS travel advisory

71

Canagliflozin-associated Peripheral Vascular Ischemia: A Case Report

72

Canal blocking strategies for hydrological restoration of degraded tropical peatlands in Central Kalimantan, Indonesia

73

Canal configuration of mandibular first premolars in an Egyptian population

74

Canal Configuration of Mesiobuccal Roots in Permanent Maxillary First Molars in Iranian Population: A Systematic Review

75

Canal of Nuck hernias

76

Canal preparation for prosthetic radial head replacement: rasping versus reaming

77

Canal surfaces in 4-dimensional Euclidean space

78

Canal Transportation and Centering Ability of ProTaper and SafeSider in Preparation of Curved Root Canals: A CBCT Evaluation

79

Canal Transportation and Centering Ability of Reciproc Blue, WaveOne Gold and ProTaper Next in Simulated Curved Canals

80

Canal Transportation and Centering Ability of Twisted File and Reciproc: A Cone-Beam Computed Tomography Assessment

81

Canal Transportation and Centering after Using PathFile and R-Pilot in Mesiobuccal Canals of Maxillary Molars Using Cone-Beam Computed Tomography

82

Canal Transportation and Centring Ability of Reciproc and Reciproc Blue With or Without Use of Glide Path Instruments: A CBCT Study

83

Canal water treatment with rapid sand filtration

84

Canaletto’s paintings open a new window on the relative sea-level rise in Venice

85

Canalicular adenoma of the hard palate: A rare case report

86

Canalicular and Naolacrimal Duct Blockage: An Ocular ide Effect Aociated With the Antineoplatic Drug -1

87

Canalicular bile formation: beyond single transporter functions

88

Canalicular fluid flow induced by bending of a long bone

89

Canalis Sinuosus Damage after Immediate Dental Implant Placement in the Esthetic Zone

90

Canalization as a non-genetic source of adaptiveness during morphogenesis: experimental evidence from analysis of reproductive development in Sorghum bicolor

91

Canalization of development and ecdysteroid timing during the last instar in lubber grasshoppers

92

Canals and Communities. Small-scale Irrigation Systems, Edited by J. Mabry, University of Arizona Press, 1996. ISBN 0816515921, pp. 273

93

Canard phenomenon for an SIS epidemic model with nonlinear incidence

94

Canard solution and its asymptotic approximation in a second-order nonlinear singularly perturbed boundary value problem with a turning point

95

Canard solutions of two-dimensional singularly perturbed systems

96

Canards and mixed-mode oscillations in a forest pest model

97

98

CANARD-WING INTERACTIONS IN SUBSONIC FLOW

99

Canary current upwelling: More or less?

100

Canary in the coalmine: Norwegian attitudes towards climate change and extreme long-haul air travel to Aotearoa/New Zealand

101

Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis

102

Canataxpropellane, a novel taxane with a unique polycyclic carbon skeleton (tricyclotaxane) from the needles of Taxus canadensis

103

Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers

104

Canavan disease: a monogenic trait with complex genomic interaction

105

Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing

106

CaNb2O6 ceramics prepared by a reaction-sintering process

107

c-ANCA as a marker of Wegenerʹs disease

108

c-ANCA as a serological pitfall

109

C-ANCA Positive Vasculitis in a Case of Amyloidosis

110

Cancarb appoints European agents for its Thermax thermal blacks

111

CAN-catalyzed syntheses of 3,4-dihydroquinoxalin-2-amine derivatives based on isocyanides

112

CAN-catalyzed three-component reaction between anilines and alkyl vinyl ethers: stereoselective synthesis of 2-methyl-1,2,3,4-tetrahydroquinolines and studies on their aromatization

113

114

Canceling out both the real and the spectral lines

115

Canceling print serials in favor of electronic: criteria for decision making

116

Cancellable biometerics featuring with tokenised random number

117

Cancellable biometrics and annotations on BioHash

118

Cancellation among finite unary algebras Original Research Article

119

Cancellation and Focus: The Role of Shared and Unique Features in the Choice Process

120

Cancellation Conditions for Finite Two-Dimensional Additive Measurement

121

Cancellation errors in an integral for calculating magnetic field from reduced scalar potential

122

Cancellation in cyclic consecutive systems

123

Cancellation is exponentially powerful for computing the determinant

124

Cancellation of bending-induced birefringence in single-mode fibers: application to Faraday sensors

125

Cancellation of Capacitor Parasitic Parameters for Noise Reduction Application

126

Cancellation of digraphs over the direct product

127

Cancellation of elective oral and maxillofacial operations

128

Cancellation of Elective Surgeries in a Tertiary Care Hospital in North India

129

Cancellation of fine-structure splitting in quantum dots by a magnetic field

130

Cancellation of Harmonic Interference by Baseline Shifting of Wavelet Packet Decomposition Coefficients

131

Cancellation of heat effects in catalytic distillation

132

Cancellation of image crosstalk in time-sequential displays of stereoscopic video

133

Cancellation of Infrared Divergences at Finite Temperature

134

cancellation of land certificate based on the court decision in indonesian legal system

135

CANCELLATION OF MASS-LOADING EFFECTS OF TRANSDUCERS AND EVALUATION OF UNMEASURED FREQUENCY RESPONSE FUNCTIONS

136

Cancellation of operations in Saudi Arabian hospitals: Frequency, reasons and suggestions for improvements

137

Cancellation of polarized impulsive noise using an azimuth-dependent conditional mean estimator

138

Cancellation of projective modules over regular rings with comparability Original Research Article

139

Cancellation of renormalon ambiguities in the heavy quark effective theory Original Research Article

140

Cancellation of second-order intermodulation distortion and enhancement of IIP2 in common-source and common-emitter RF transconductors

141

Cancellation of Series-Loss Resistance in UWB Active Inductors using RC Feedback

142

Cancellation of Simulated Environmental Noise as a Tool for Measuring Vocal Performance During Noise Exposure

143

Cancellation of star light generated by a nearby star–planet system upon detection with a rotationally-shearing interferometer

144

Cancellation of Sudakov logarithms in radiative decays of quarkonia Original Research Article

145

Cancellation of the Heating Piston Effect by Convective Enhancement of a Cooling Piston Effect

146

Cancellation problem of preconditioning method at low Mach numbers

147

Cancellation properties for quotient divisible groups

148

Cancellation properties of products of graphs

149

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

150

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

151

Cancellation provisions in Australiaʹs Commonwealth-managed fisheries

152

Cancellation task in very low educated people

153

Cancellation techniques in underwater scattering of acoustic signals

154

Cancellation Theorems Related to Conjectures of Alperin and Dade

155

Cancellations in ambulatory day surgery: Ten years observational study

156

Cancellations in day-case ENT surgery

157

Cancellations in neutrinoless double beta decay and the neutrino mass matrix Original Research Article

158

Cancellative pairs of families of sets

159

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part I)

160

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part II)

161

Cancellativity properties for t-norms and t-subnorms

162

Cancelled IGF-1 trials bode ill for diabetic patients

163

Cancelling Jüttner distributions for space-like freeze-out

164

Cancelling quadratic divergences without supersymmetry Original Research Article

165

Cancelling vibrations in flexible articulated structures using non-causal inverse dynamics

166

Cancellous and cortical bone mineral density around an elastic press-fi t socket in total hip arthroplasty

167

Cancellous and cortical morselized allograft in revision total hip replacement:: A biomechanical study of implant stability

168

Cancellous bone architecture: Advantages of nonorthogonal trabecular alignment under multidirectional joint loading

169

Cancellous bone biomechanics

170

Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: Separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)

171

Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level

172

Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution

173

Cancellous bone repair using bovine trabecular bone matrix particulates

174

Cancellous impaction and cortical strut allografting for revision shoulder arthroplasty: A case report

175

176

Cancer – Blame it all on viruses! Bladder tumours in cattle and sarcoids in horses may help us understand the relationship between some cancers and viruses

177

Cancer Risk in Pakistan Due to Natural Environmental Pollutants

178

Cancer “challenge” to limited-resource countries

179

Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity

180

Cancer among Farmers: A Meta-Analysis

181

Cancer and a Fatiguing Illness in Northern Nevada—A Causal Hypothesis

182

Cancer and aging: The molecular pathways

183

Cancer and Body Composition: An Association of Global Relevance

184

Cancer and comorbidity in older patients: A descriptive profile

185

Cancer and Complications of Peptic Ulcer in Type 2 Diabetes Mellitus patients at Wasit province, Iraq

186

cancer and covid-19: the synergistic burden on mental health status of patients with cancer

187

Cancer and Emotion; the Scope of Psycho‐Socio‐Oncology

188

Cancer and Emotion; The Scope of Psycho‐Socio‐Oncology: At the Time of Diagnosis

189

Cancer and Emotion; The Scope of Psycho-Socio-Oncology: At the Time of Treatment

190

Cancer and globalization

191

Cancer and HIV infection in Rwanda

192

Cancer and incontinence

193

Cancer and inflammation: A complex relationship

194

Cancer and its Treatment in Main Ancient Books of Islamic Iranian Traditional Medicine (7th to 14th Century AD)

195

Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of Cancer

196

Cancer and male infertility

197

Cancer and mutant DNA in blood plasma

198

Cancer and natural medicine: Textbook of basic science and clinical research: By John Boik, Oregon Medical Press, 1996

199

Cancer and Non-Cancer Risk of Arsenic in Drinking Water: A Case Study

200

Cancer and nonextensive statistics

201

Cancer and ovarian tissue cryopreservation

202

Cancer and psychosocial distress: frequent companions

203

Cancer and self-help: Bridging the troubled Waters of childhood illness : By Mark A. Chesler and Barbara K. Chesney. The University of Wisconsin Press, Madison, WI, 1995. 416 pp

204

Cancer and the human genome: no quick fix

205

Cancer and the meaning of work

206

Cancer and thromboembolic disease: how important is the risk of thrombosis?

207

Cancer and thromboembolic disease: pathogenic mechanisms

208

Cancer and thrombosis revisited

209

Cancer and venous thromboembolism

210

Cancer and Women’s Health

211

Cancer and wood-related occupational exposure in the Amazon region of Brazil

212

Cancer anorexia and cachexia

213

Cancer anorexia: a model for the understanding and treatment of secondary anorexia

214

Cancer anorexia: new pathogenic andtherapeutic insights

215

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

216

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

217

Cancer as a Complex Genetic Trait: Tumor Susceptibility in Humans and Mouse Models

218

Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway

219

Cancer associated with obstetric delivery: results of linkage with the California cancer registry

220

Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients

221

Cancer biology for the clinic and the lab

222

Cancer biomarker and neurotransmitters recognition by molecularly imprinted xero-gels

223

Cancer Biomarkers

224

Cancer biomarkers

225

Cancer biomarkers detection using 3D microstructured protein chip: Implementation of customized multiplex immunoassay

226

Cancer Biomarkers: Closer to Delivering on their Promise

227

Cancer Biopsy in Ancient Persian Medicine: Do or Not to Do!

228

Cancer bio-repository

229

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

230

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

231

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

232

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

233

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive

234

Cancer bronchique non à petites cellules: mise au point en 1998

235

Cancer bronchique : le drainage lymphatique

236

Cancer burden and trends in the asian pacific RIM region

237

Cancer cachexia

238

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation

239

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

240

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

241

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

242

Cancer cachexia: Metabolic alterations and clinical manifestations

243

Cancer Cancer vaccines: a road map for the next decade

244

Cancer care during the natural disasters, the lessons learned from Kermanshah Earthquake in 2017

245

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations

246

Cancer cell detection in tissue sections using AFM

247

Cancer cell dissemination during curative surgery for colorectal liver metastases

248

Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data

249

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

250

Cancer Cell Metabolism: Warburg and Beyond

251

Cancer Cell progression

252

Cancer Cell Separation Using Passive Mechanisms: a Review

253

Cancer cell separator using size-dependent filtration in microfluidic chip

254

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

255

Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

256

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains

257

Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate

258

Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor study

259

Cancer chemoprevention with garlic and its constituents

260

Cancer Chemoprevention. Vol. 2: Strategies for Cancer Chemoprevention.G.J. Kellof, E.T. Hawk and C.C. Sigman, Editors, Humana Press, Totowa (2005).

261

Cancer Chemoprevention. Volume I. Promising Cancer Chemopreventive Agents.G.J. Kelloff, E. T. Hawk and C.C. Sigman, Editors, P. Humana Press, Totowa (2004)

262

Cancer chemoprevention: A radical perspective

263

Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants

264

Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis

265

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

266

Cancer chemopreventive activity of acridone alkaloids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

267

Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens

268

Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.

269

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis

270

Cancer chemopreventive activity of flavanones on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

271

Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis

272

Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants

273

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

274

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

275

Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis

276

Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations

277

Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum

278

Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr

279

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis

280

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

281

Cancer chemopreventive effect of dietary Zataria multiflora essential oils

282

Cancer chemopreventive effect of orally administrated lupane-type triterpenoid on ultraviolet light B induced photocarcinogenesis of hairless mouse

283

Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus activation

284

Cancer chemopreventive effects of constituents of Caesalpinia ferrea and related compounds

285

Cancer chemopreventive effects of oral feeding α-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse

286

Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice

287

Cancer chemopreventive effects of polyunsaturated fatty acids

288

Cancer Chemo-Preventive Effects of Red Propolis: a System Biology Approach

289

Cancer chemopreventive oltipraz generates superoxide anion radical

290

Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations

291

Cancer chemotherapy – ribonucleases to the rescue Review Article

292

Cancer Chemotherapy and Biotherapy

293

Cancer chemotherapy in the older cancer patient

294

Cancer chemotherapy optimization under evolving drug resistance Original Research Article

295

Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

296

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

297

Cancer chemotherapy: A SN-38 (7-Ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug monoTherapy) strategy

298

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

299

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

300

Cancer Classification in Microarray Data using a Hybrid Selective Independent Component Analysis and υ‑Support Vector Machine Algorithm

301

Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble

302

Cancer Control at the Workplace: The Working Well Trial

303

Cancer Control strategy in the world, a review article

304

Cancer control: a reminder of the need for a balanced approach between prevention and treatment

305

Cancer cutané et xéroderma pigmentosum

306

Cancer cutané et xéroderma pigmentosum

307

Cancer de l’endomètre de stade I

308

Cancer de l’estomac : doses et volumes-cibles

309

Cancer de l’estomac. Le point thérapeutique en 2008

310

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

311

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

312

Cancer de la prostate

313

Cancer de la prostate 2010. Innovations thérapeutiques

314

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

315

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

316

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

317

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

318

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

319

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

320

Cancer de la thyroïde après exposition aux rayonnements ionisants

321

Cancer de lʹœsophage : répercussion des thérapeutiques néoadjuvantes sur la morbidité et la mortalité opératoire

322

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

323

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

324

Cancer de prostate localisé. Que dire au patient ?

325

Cancer de prostate : doses et volumes cibles

326

Cancer death epidemics in United States Black males: Evaluating courses, causation, and cures

327

CANCER DEATH RATES AND BACKGROUND RADIATION

328

Cancer detection and mammogram volume of radiologists in a population-based screening programme

329

Cancer detection from textual data using a combination of machine learning approach

330

Cancer Detection Using Aritifical Neural Network and Support Vector Machine: A Comparative Study

331

Cancer Development and Electromagnetic Fields in Near Future

332

Cancer diagnosis by autofluorescence of blood components

333

Cancer Diagnosis Disclosure: What is the Right Thing to Do?

334

Cancer Diagnosis in Endoscopic Images using Discrete Wavelet Transform

335

Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study

336

Cancer Disclosure in Iran: Attitude of Patients and Their Families

337

Cancer disclosure in Japan: Historical comparisons, current practices

338

Cancer distress screening: Needs, models, and methods

339

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

340

Cancer driver mutations in protein kinase genes

341

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

342

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

343

Cancer du cavum au centre tunisien : à propos de 525 cas

344

Cancer du cavum au centre tunisien : à propos de 525 cas

345

Cancer du cavum chez le sujet jeune

346

Cancer du cavum chez le sujet jeune

347

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

348

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

349

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

350

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

351

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

352

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

353

Cancer du cavum dans le centre tunisien : facteurs pronostiques

354

Cancer du cavum dans le centre tunisien : facteurs pronostiques

355

Cancer du cavum du sujet âgé

356

Cancer du cavum du sujet âgé

357

Cancer du cavum et syndromes paranéoplasiques

358

Cancer du cavum et syndromes paranéoplasiques

359

Cancer du col utérin

360

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

361

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

362

Cancer du col utérin stades IB et II opérable : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première suivies d’une radiothérapie

363

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

364

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

365

Cancer du larynx chez le sujet âgé

366

Cancer du larynx chez le sujet âgé

367

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

368

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

369

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

370

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

371

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

372

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

373

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

374

Cancer du rectum avec métastases synchrone

375

Cancer du rectum avec métastases synchrone

376

Cancer du rectum chez le sujet de moins de 40 ans

377

Cancer du rectum chez le sujet de moins de 40 ans

378

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

379

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

380

Cancer du rectum : volumes cibles de la radiothérapie préopératoire

381

382

Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas

383

Cancer du sein chez la femme âgée

384

Cancer du sein chez la femme âgée

385

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

386

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

387

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

388

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

389

Cancer du sein chez la femme jeune au Maroc

390

Cancer du sein chez la personne âgée : place de la radiothérapie ?

391

Cancer du sein chez la personne âgée : place de la radiothérapie ?

392

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

393

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

394

Cancer du sein de la femme de moins de 35 ans

395

Cancer du sein de la femme de moins de 35 ans

396

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

397

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

398

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

399

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

400

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

401

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

402

Cancer du sein localement évolué non inflammatoire traité par association de chimiothérapie et de radiothérapie à dose préopératoire : réactualisation des résultats d’une série de 120 patientes

403

Cancer du sein métastatiques : intérêt du CA 15-3

404

Cancer du sein métastatiques : intérêt du CA 15-3

405

Cancer du sein négligé et localement évolué : quelle réalité ? Réflexion à propos de deux cas sur l’optimisation de la prise en charge multidisciplinaire

406

Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature

407

Cancer du sein traité exclusivement par l’association d’une irradiation externe et d’une curiethérapie exclusive : résultats à long terme

408

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

409

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

410

Cancer du sein. Questions et réponses au quotidien, J Saglier, EC Antoine. Masson, New York (1996), 125

411

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

412

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

413

Cancer education among primary care physicians in an underserved community

414

Cancer epidemiology and trends in Sistan and Baluchestan province, Iran

415

Cancer Epidemiology in Lebanon

416

Cancer Epidemiology in Radiation Oncology: An Institutional Experience From North India During 2016-2022

417

Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention

418

Cancer epigenetics as biomarkers of clinical significance

419

Cancer epigenetics is no Mickey Mouse

420

Cancer epigenetics is no Mickey Mouse

421

Cancer Epigenetics: From Mechanism to Therapy

422

CANCER ESOPHAGUS: AN AUDIT OF CURRENT MANAGEMENT FOR YEMENI PATIENTS

423

Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature

424

Cancer experts square up for European funds

425

Cancer familiarity status in patients with early brest cancer: Our experience

426

Cancer fatalism among african-americans: A review of the literature

427

Cancer Feature Selection and Classification Using a Binary Quantum-Behaved Particle Swarm Optimization and Support Vector Machine

428

Cancer gene may move quickly into skin clinics

429

Cancer gene therapy targeting cellular apoptosis machinery

430

Cancer genes and molecular oncology in the clinic

431

Cancer gene-therapy: clinical trials

432

Cancer Genetics and Cytogenetics

433

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

434

Cancer genetics and genomics of human FOX family genes

435

Cancer Genetics and the Cardiotoxicity of the Therapeutics

436

Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

437

Cancer Genomes Evolve by Pulverizing Single Chromosomes

438

Cancer genomics

439

Cancer Genomics: The Road Ahead

440

Cancer groups meet in Edinburgh

441

cancer has an independent association with death in hospitalized patients with covid-19: a single-center study in iran

442

Cancer hazard identification and qualitative risk assessment

443

Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges

444

Cancer hopes and setbacks

445

Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer

446

Cancer immunoprevention: tracking down persistent tumor antigens

447

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

448

Cancer immunotherapy – broader considerations

449

Cancer Immunotherapy Using Microfluidic Systems

450

Cancer immunotherapy, mathematical modeling and optimal control

451

Cancer immunotherapy: novel strategies and clinical experiences

452

Cancer immunotherapy: simply cell biology?

453

Cancer immunotherapyʹs renaissance

454

Cancer in home care: Unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe

455

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)

456

Cancer in Korean War Navy Technicians: Mortality Survey after 40 Years

457

Cancer in Lebanon: An Epidemiological Review of the American University of Beirut Medical Center Tumor Registry (1983–1994)

458

Cancer in married couples: Higher or lower distress?

459

Cancer in Maysan: Mortality, Pattern, and Demographic Characteristics during the Last 4 Decades

460

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Original Research Article

461

Cancer in patients on renal replacement therapy in Lombardy, Italy

462

Cancer in people with depression or anxiety: record-linkage study

463

Cancer in pregnancy: Gaps, challenges and solutions

464

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

465

Cancer in the mass print media: Fear, uncertainty and the medical model

466

Cancer in the older person

467

Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors Original Research Article

468

Cancer incidence among Danish Seventh-day Adventists and Baptists

469

Cancer incidence among Mormons and non-Mormons in Utah (United States) 1995–1999

470

Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study

471

Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999

472

Cancer Incidence among the Elderly Population in the Northwest of Iran: A Population Based Study

473

Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998

474

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

475

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

476

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

477

Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006

478

Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987–2007

479

Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015

480

Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 – 2010

481

Cancer Incidence around an Oil Refinery as an Example of a Small Area Study Based on Map Coordinates

482

Cancer incidence estimation at a district level without a national registry: A validation study for 24 cancer sites using French health insurance and registry data

483

Cancer incidence in a petrochemical industry area in Sweden Original Research Article

484

Cancer incidence in children conceived with assisted reproduction technology

485

Cancer incidence in Dutch Balkan veterans

486

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population

487

Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

488

Cancer incidence in Jordan, 1996–2005

489

Cancer Incidence in Montana: Rates for American Indians Exceed Those for Whites Original Research Article

490

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

491

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998

492

Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry

493

Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 – 2001

494

Cancer incidence in the USA could double by 2050, report predicts

495

Cancer incidence in women exposed to DES in utero

496

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

497

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

498

Cancer Incidence Rates among Iranian immigrants in Sweden, a Population-Based Retrospective Cohort Study

499

Cancer Incidence, Mortality and Survival in Türkiye as of 2020

500

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

501

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

502

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

503

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

504

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

505

Cancer informatics by prototype networks in mass spectrometry

506

Cancer Information Service-Initiated Outcalls to Promote Screening Mammography among Low-Income and Minority Women: Design and Feasibility Testing, ,

507

Cancer initiation by fumonisin B1 in rat liver – role of cell proliferation

508

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

509

Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon

510

Cancer letters special issue hepatocellular carcinoma featuring the guest editors

511

Cancer Letters special issue inflammation and gastrointestinal and liver cancers featuring the guest editor

512

Cancer Letters. Featuring the guest editors: Wael M. ElShamy and Roy J. Duhé

513

Cancer magnitude, challenges and control in the Eastern Mediterranean Region

514

Cancer marker detection in human serum with a point-of-care low-cost system

515

Cancer metabolism and the dynamics of metastasis

516

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

517

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

518

Cancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis

519

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

520

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)

521

Cancer Modeling and Simulation, L. Preziosi (Ed.). Chapman and Hall/CRC (2003)

522

Cancer Modeling in the Modern Era: Progress and Challenges

523

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

524

Cancer molecules reveal their mechanisms

525

Cancer morbidity in subjects occupationally exposed to high frequency (radiofrequency and microwave) electromagnetic radiation

526

Cancer mortality among agricultural workers from Serrana Region, state of Rio de Janeiro, Brazil

527

Cancer mortality among workers in formaldehyde industries

528

Cancer mortality among workers in the meat department of supermarkets : E. S. Johnson, Occupational and Environmental Medicine, 51(8), 541–547

529

Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland

530

Cancer mortality and offset printing

531

Cancer mortality and prevention in the European Union

532

Cancer mortality around French nuclear sites

533

Cancer mortality in Basrah: a household survey results

534

Cancer nanomedicine: A review on approaches and applications towards targeted drug delivery

535

Cancer nanomedicines targeting tumor extracellular pH

536

Cancer nanomedicines: So many papers and so few drugs!

537

Cancer nanotechnology

538

Cancer nanotechnology

539

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

540

Cancer Nursing: Care in Context: Jessica Corner, Christopher Bailey (Eds.); Blackwell Science, Oxford, 2001, ISBN 0-632-03998-1

541

Cancer Occurrence in Fars Province, Southern Iran

542

Cancer Occurrence in the Elderly: Agreement between Three Major Data Sources

543

Cancer of children in Basrah-Iraq: Person and time characteristics

544

Cancer of Male Urethra: Case Series and Review of Literature

545

Cancer of the breast, fifth edition.: William L. Donegan and John S. Spratt publisher: Saunders, Philadelphia, pages: 1,025. price: $179.00

546

Cancer of the breast: Is radiation therapy curative

547

Cancer of the Colon and Rectum in California: Trends in Incidence by Race/Ethnicity, Stage, and Subsite,

548

Cancer of the esophagus: histopathological sub-types in northern Uganda

549

Cancer of the gastric cardia

550

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation

551

Cancer of the larynx in females

552

Cancer of the larynx in Hong Kong: a clinico-pathological study

553

Cancer of the pharynx and larynx

554

Cancer of the rectum—palliative endoscopic treatment

555

Cancer of unknown primary origin: a decade of experience in a community-based hospital

556

Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?

557

Cancer omics: From regulatory networks to clinical outcomes

558

Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks

559

Cancer pain relief achieved in mice with proenkephalin-expressing herpes vector

560

Cancer pain relief, 2nd Edn : WHO, Geneva. £11.90, ISBN 92 4 154482 1

561

Cancer Pain; Physical Factors affecting Pain Experience

562

Cancer paper retracted

563

Cancer patient advocacy: New opportunities for treatment advances

564

Cancer patient survival in Estonia 1995–2009: Time trends and data quality

565

Cancer patients and loneliness: A systematic review

566

Cancer patients desire for information: a study in a teaching hospita l in Saudi Arabia

567

Cancer patients overestimate survival chances

568

Cancer patients' satisfaction with communication and information given by nurses at teaching hospitals of Tehran, Iran

569

Cancer patientsʹ satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results

570

Cancer Patients Who Elect Euthanasia as an Option: An Argumentative Essay

571

Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making i

572

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

573

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

574

Cancer patients’ reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: A preliminary study

575

Cancer pattern and survival in a rural district in South India

576

Cancer prevention

577

Cancer Prevention - Behavior Changes: The Short and the Long of It

578

Cancer prevention – the potential for diet to modulate molecular signalling

579

Cancer Prevention & Control Strategy: Resolution adopted by the 58th World Health Assembly, Geneva, May 25, 2005

580

Cancer Prevention Among Urban Southwestern American Indian Women: Comparison to Selected Year 2000 National Health Objectives

581

Cancer prevention by carotenoids

582

Cancer prevention by food factors through targeting signal transduction pathways,

583

Cancer Prevention by Protease Inhibitors

584

Cancer prevention by tocopherols and tea polyphenols

585

Cancer prevention in primary care: Predictors of patient counseling across four risk behaviors over 24 months

586

Cancer prevention in rural primary care: An academic-practice partnership

587

Cancer prevention studies: Past, present, and future directions

588

Cancer prevention studies—Past, present, and future directions

589

Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

590

Cancer Prevention: Chemoprevention vs Dietary Modifications

591

Cancer prevention: epidemiology and experiment

592

Cancer Prevention; Cancer Risk Management

593

Cancer Prevention; Emerging Infectious Diseases as Risk Factors, Iran Feature

594

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters Original Research Article

595

Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Original Research Article

596

Cancer preventive effects of flavonoids—a review

597

Cancer preventive potential of trichothecenes from Trichothecium roseum Original Research Article

598

Cancer preventive properties of ginger: A brief review

599

Cancer preventive screening: A cross-border comparison of United States and Canadian Chinese women

600

Cancer procoagulant and blood platelet activation

601

Cancer progression and p53

602

Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer

603

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

604

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

605

Cancer proteomics: from signaling networks to tumor markers

606

Cancer proteomics: from signaling networks to tumor markers

607

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

608

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

609

Cancer rectocolique chez le sujet jeune

610

Cancer rectocolique chez le sujet jeune

611

Cancer Registry in Iran: a Brief Overview

612

Cancer related factors do not explain the quality of life scores for childhood cancer survivors analysed with two different generic HRQL instruments

613

Cancer Related Fears in Iranian Patients, a Survey from South East of Iran

614

Cancer related inflammation: The macrophage connection

615

Cancer research priorities for early diagnosis in Iran: Analyses based on Multiple-Attribute Decision Making Model

616

Cancer Research Studies in Native Hawaiians and Pacific Islanders

617

Cancer Research UK looks to NCI forsuccess

618

Cancer researchers get down to arrays at AACR

619

Cancer Resection on the Residual Lung After Pneumonectomy for Bronchogenic Carcinoma

620

Cancer responds better to combined treatments

621

Cancer risk above 1 Gy and the impact for space radiation protection Original Research Article

622

Cancer risk after a hospital discharge diagnosis of endometriosis, , ,

623

Cancer risk after non-melanoma skin cancer

624

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

625

Cancer risk analysis by fuzzy logic approach and performance status of the model

626

Cancer Risk Analysis of Benzene and Ethyl Benzene in Painters

627

Cancer risk and all-cause mortality among Norwegian military United Nations peacekeepers deployed to Kosovo between 1999 and 2011

628

Cancer risk and Barrett’s esophagus

629

Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

630

Cancer Risk Assessment Benzene, Toluene, Ethylbenzene and Xylene (BTEX) in the Production of Insulation Bituminous

631

Cancer Risk Assessment due to Accidental Exposure inside Neutron Laboratories using BEIR VII Model

632

Cancer risk assessment for Tehran research reactor and radioisotope laboratory with CAP88-PC code (Gaussian plume model)

633

Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran

634

Cancer Risk Assessment From Multi-Exposure to Chloroform in Drinking Water of Ilam City, Iran

635

Cancer risk assessment from trihalomethanes in drinking water

636

Cancer Risk Assessment in Welder's Under Different Exposure Scenarios

637

Cancer risk assessment using blood dioxin levels and daily dietary TEQ intake in general populations of industrial and non-industrial countries

638

Cancer Risk Assessment: Evolution of the Process

639

Cancer Risk Assessment: Quality and Impact of the Family History Interview

640

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty

641

Cancer risk due to contamination: Consideration from market basket survey in Qatar

642

Cancer risk factors among men of diverse Hispanic or Latino origins

643

Cancer risk in endoscopically unresectable colon polyps

644

Cancer risk in hypertensive patients treated with calcium channel blockers

645

Cancer risk in menopausal women

646

Cancer risk in patients on dialysis

647

Cancer risk in patients on dialysis and after renal transplantation Original Research Article

648

Cancer risk in patients with monoclonal gammopathy of undetermined significance

649

Cancer risk models and preselection for screening

650

Cancer risk, hypertension, and antihypertensive medication

651

Cancer risks associated with the diagnosis of infertility

652

Cancer risks in children with congenital malformations in the nervous and circulatory system—A population based cohort study

653

Cancer screening among Latino subgroups in the United States

654

Cancer screening among older women in a culturally insular community

655

Cancer Screening Among the Overweight and Obese in Canada Original Research Article

656

Cancer screening and prevention practices of inner-city physicians

657

Cancer screening behaviors among smokers and non-smokers

658

Cancer Screening Benefits Maximization Using Markov Decision Process Models: A Systematic Review

659

Cancer screening estimates for U.S. metropolitan areas Original Research Article

660

Cancer Screening Guidelines: A Rapid Review

661

Cancer screening in end-stage renal disease

662

Cancer Screening in HMOs:: Program Development and Evaluation

663

Cancer screening in the elderly

664

Cancer Screening in Women: Body Mass Index and Adherence to Physician Recommendations Original Research Article

665

Cancer screening knowledge, attitudes, and behaviors among culturally Deaf adults: Implications for informed decision making

666

Cancer Screening Practice among Iranian Middleaged Women

667

Cancer screening practices among cancer survivors Original Research Article

668

Cancer screening with whole-body F-fluorodeoxyglucose positron-emission tomography

669

Cancer Screening, Effective or Harmful?

670

Cancer Screening, Effective or Harmful?

671

Cancer Screening: Knowledge, Attitudes, and Practices among Healthcare Personnel

672

Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?

673

Cancer self remission and tumor stability – a stochastic approach

674

Cancer should be prioritised on WHO agenda

675

Cancer Statistics in I.R. Iran in 2020

676

Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, China

677

Cancer stem cell biomarkers: critical roles, challenges, clinical applications and perspectives in cancer therapy

678

Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame?

679

Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter

680

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

681

Cancer stem cell markers in common cancers – therapeutic implications

682

Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study

683

Cancer Stem Cell’s Potential Clinical Implications

684

Cancer Stem Cell’s Potential Clinical Implications

685

Cancer stem cells (CSCs): the blockage of metastatic and stemness properties by metal nanoparticles

686

Cancer Stem Cells and Oral Carcinogenesis; a Review Article

687

Cancer stem cells and telomerase as potential biomarkers in veterinary oncology

688

Cancer stem cells and tumor angiogenesis

689

Cancer stem cells as the engine of unstable tumor progression

690

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran

691

Cancer stem cells hypothesis and stem cells in head and neck cancers

692

Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective

693

Cancer stem cells in multiple myeloma

694

Cancer stem cells in urologic cancers

695

Cancer stem cells may drive growth of paediatric brain tumours

696

Cancer stem cells niche: A target for novel cancer therapeutics

697

Cancer stem cells sustaining the growth of mouse melanoma are not rare

698

Cancer stem cells, CD200 and immunoevasion

699

Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia

700

Cancer stem cells: A contentious hypothesis now moving forward

701

Cancer stem cells: Beyond Koch’s postulates

702

Cancer stem cells: emerging actors in both basic and clinical cancer research

703

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

704

Cancer stem cells: In the line of fire

705

Cancer stem cells: New therapeutic targets?

706

Cancer stem cells: potential target for bioactive food components

707

Cancer stem cells: Recent developments and future prospects

708

Cancer Stem Cells: Targets for treatment of malignancies to overcome drug resistance

709

Cancer stem cells: Toward novel anti-cancer therapies?

710

Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway

711

Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer

712

Cancer stromal targeting (CAST) therapy

713

Cancer surgery in the elderly—overall conclusions

714

Cancer surgery: the last 25 years

715

Cancer surveillance in Italian army peacekeeping troops deployed in Bosnia and Kosovo, 1996–2007: Preliminary results

716

Cancer survival

717

Cancer survival

718

Cancer survival as a function of age at diagnosis: A study of the Surveillance, Epidemiology and End Results database

719

Cancer survival classification using integrated data sets and intermediate information

720

Cancer survival in New Zealand: Ethnic, social and geographical inequalities

721

Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: A population-based cohort study

722

Cancer survival is no lottery

723

Cancer survival rates and GDP expenditure on health: a comparison of England and Wales and the USA, Denmark, Netherlands, Finland, France, Germany, Italy, Spain and Switzerland in the 1990s

724

Cancer Susceptibility and the Functions of BRCA1 and BRCA2

725

Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles

726

Cancer Terminologies Used in the Medieval Texts to the Early Modern Iranian Traditional Medicine (ITM)

727

Cancer theranostics: the rise of targeted magnetic nanoparticles

728

Cancer therapeutics in yeast

729

Cancer therapy with particle accelerators Original Research Article

730

Cancer therapy with phytochemicals: evidence from clinical studies

731

Cancer therapy: can the challenge be MET?

732

Cancer treatment by telomerase inhibitors: predictions by a kinetic model

733

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies

734

CANCER TREATMENT -OBJECTIVES AND QUALITY OF LIFE ISSUES

735

Cancer treatment reviews welcomes submission of the Cochrane Reviews

736

Cancer Treatment with the Alternative Herbal Medicine HUMA: Two Case Reports

737

Cancer treatment: the last 25 years

738

Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?

739

Cancer Trends and the Importance of Prevention

740

Cancer trends in a province of Southwest of Iran, 2003–2016

741

Cancer tribe gathers

742

Cancer truth disclosure by Lebanese doctors

743

Cancer Tumor antigens

744

Cancer Turning in on death programs

745

Cancer types in dermatomyositis and polymyositis

746

Cancer types in dermatomyositis and polymyositis

747

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011 - 2013)

748

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011 - 2013).

749

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011-2013)

750

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011-2013)

751

Cancer vaccination progress

752

Cancer vaccines: a step towards prevention and treatment of cancer

753

Cancer vaccines: Harnessing the potential of anti-tumor immunity

754

Cancer Vulnerabilities Unveiled by Genomic Loss

755

Cancer warnings for West Bengalis drinking arsenic-contaminated water

756

Cancer Wars: How politics shapes what we know and donʹt know about cancer : Robert N. Proctor Basic Books, New York (1995) 356pp, indexes ISBN 0 465 02756 3 $25 hardback

757

Cancer wasting and quality of life react to early individualized nutritional counselling!

758

Cancer, A Big Monster, Which Should Be Defeated / The Editorial

759

Cancer, cancer cachexia, and diet: lessons from clinical research

760

Cancer, Chemotherapy, and Cor Pulmonale

761

Cancer, dépression et anxiété

762

Cancer, Somatic Mutation and Stem Cells

763

Cancer/radiothérapie

764

Cancer/testis antigens: A prospective reagent as diagnostic and immunotherapeutic targets for squamous cell carcinoma of the head and neck

765

Cancer/Testis genes in relation to sperm biology and function

766

Cancer: #1 The relationship of reproductive and body composition factors on the stage of cancer at diagnosis among non-hispanic white and hispanic postmenopausal breast cancer cases

767

Cancer: a lesson for us all

768

Cancer: A Systems Biology disease

769

Cancer: care or cure?

770

Cancer: Disease Caused by Alteration of Genes

771

Cancer: Editorial overview

772

Cancer: Editorial overview

773

Cancer: impact of nutrition intervention outcome—nutrition issues for patients

774

Cancer: Some genetic considerations

775

Cancer: Surviving on the edge

776

Cancer: The Future features in Iran

777

Cancer—a call for papers

778

Cancer—a call for papers

779

Cancer—a degenerative disorder?

780

Cancer-aociated Nummular Lo of the Pigment Epithelium

781

Cancer-aociated retinopathy aociated with invaive thymoma

782

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

783

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

784

Cancer-associated genodermatoses and familial cancer syndromes with cutaneous manifestations

785

Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy

786

Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation

787

Cancer-Associated Mutations in BRC Domains of BRCA2 Affect Homologous Recombination Induced by Rad51

788

Cancer-associated thrombosis

789

Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function

790

cancer-curative potential of novel coumarins from watermelon princess: a scenario of their isolation and activity

791

Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up

792

Cancerous Tissue Diagnosis by LIF Spectroscopy Derived From Body-Compatible Fluorophores

793

Cancer-Preventive Effects of Drinking Green Tea among a Japanese Population,

794

Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress

795

Cancer-Preventive Selenocompounds Induce a Specific Redox Modification of Cysteine-Rich Regions in Ca2+- Dependent Isoenzymes of Protein Kinase C

796

Cancer-registry data in Latvia

797

Cancer-related fatigue: Links with inflammation in cancer patients and survivors

798

Cancer-related fears: A significant psychological burden in cancer patients and their caregivers

799

Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam

800

Cancer-Related Self-Efficacy in Iranian Women With Breast Cancer

801

Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis

802

Cancer-risk benefits of clean fuel technology and policy: A statistical analysis

803

Cancers after Renal Transplantation: Multicenter Experience

804

Cancers bronchiques non à petites cellules avec oligométastases : prise en charge chirurgicale à visée curative

805

Cancers bronchiques non à petites cellules de stade I : radiothérapie tridimensionnelle et radiothérapie en conditions stéréotaxiques

806

Cancers bronchiques non à petites cellules de stade I : radiothérapie tridimensionnelle et radiothérapie en conditions stéréotaxiques

807

Cancers bronchiques non à petites cellules localement évolués : curiethérapie de haut débit de dose complémentaire dʹune radiothérapie externe à visée curative

808

Cancers bronchiques non à petites cellules : amélioration des chances de survie par la radiothérapie conformationnelle ?

809

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

810

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

811

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

812

Cancers bronchiques traités par irradiation tridimensionnelle : influence de la délinéation pulmonaire en mode automatique seul ou en mode automatique excluant le volume cible prévisionnel

813

Cancers bronchiques traités par irradiation tridimensionnelle : influence de la délinéation pulmonaire en mode automatique seul ou en mode automatique excluant le volume cible prévisionnel

814

Cancers bronchiques : la radiothérapie prophylactique des aires ganglionnaires a-t-elle encore une place ?

815

Cancers bronchopulmonaires chez le sujet jeune

816

Cancers bronchopulmonaires chez le sujet jeune

817

Cancers de l’amygdale : peut-on ne pas irradier les patients en situation de bonne réponse à la chimiothérapie d’induction ?

818

Cancers de l’amygdale : peut-on ne pas irradier les patients en situation de bonne réponse à la chimiothérapie d’induction ?

819

Cancers de la cavité buccale : à propos de 145 cas à l’institut Joliot-Curie de Dakar

820

Cancers de la cavité buccale : à propos de 145 cas à l’institut Joliot-Curie de Dakar

821

Cancers de la prostate

822

Cancers de la tête et du cou

823

Cancers de prostate : le traitement local par irradiation a-t-il un impact sur la survie ?

824

Cancers de prostate : quelle place pour la radiothérapie à visée curative chez les patients âgés ?

825

Cancers de prostate : quelles techniques de radiothérapie pour quelles tumeurs ? Enjeux éthiques et méthodologiques

826

Cancers de VADS

827

Cancers des voies aérodigestives supérieures : bénéfices cliniques de la radiothérapie conformationnelle et de la modulation d’intensité

828

Cancers des voies aérodigestives supérieures : le retour de la chimiothérapie néoadjuvante ?

829

Cancers du foie et des voies biliaires

830

Cancers du nasopharynx chez l’enfant et l’adolescent : aspects particuliers

831

Cancers du nasopharynx chez l’enfant et l’adolescent : aspects particuliers

832

Cancers du poumon non à petites cellules

833

Cancers du rectum : la chimioradiothérapie préopératoire, nouveau standard

834

Cancers du rectum : volumes cible de la radiothérapie, bases rationnelles

835

Cancers du sein après radiothérapie : facteurs de risque et proposition de définition du sein chez la jeune fille prépubère comme organe à risque

836

Cancers du sein après radiothérapie : facteurs de risque et proposition de définition du sein chez la jeune fille prépubère comme organe à risque

837

Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

838

Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

839

Cancers du sein de stade II-IIIA : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

840

Cancers du sein localement évolués (T3-T4b) avec curage ganglionnaire négatif (sans chimiothérapie néoadjuvante) : profil évolutif et facteurs pronostiques

841

Cancers du sein localement évolués (T3-T4b) avec curage ganglionnaire négatif (sans chimiothérapie néoadjuvante) : profil évolutif et facteurs pronostiques

842

Cancers du sein radio-induits présentant des caractéristiques anatomopathologiques agressives : étude rétrospective du comité de suivi à long terme de la Société française des cancers de l’enfant

843

Cancers du sein radio-induits présentant des caractéristiques anatomopathologiques agressives : étude rétrospective du comité de suivi à long terme de la Société française des cancers de l’enfant

844

Cancers du sein : comment associer l’hormonothérapie et la radiothérapie en situation adjuvante ?

845

Cancers of the blood from benzene

846

Cancers of the Brain and CNS: Global Patterns and Trends in Incidence

847

Cancers of the salivary gland: Workplace risks among women and men

848

Cancers of the Upper Gastro-intestinal Tract: A Review of Somatic Mutation Distributions

849

Cancers of Urinary System; Prevalence, Demographic

850

Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat

851

Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat

852

Cancers radio-induits: le point en 1997

853

Cancers rectocoliques chez le sujet de moins de 40 ans

854

Cancers secondaires ou seconds cancers ?

855

Cancers secondaires ou seconds cancers ?

856

Cancerʹs sweet tooth

857

Cancerʹs sweet tooth: the Janus effect of glucose metabolism in tumorigenesis

858

Cancers, Mainly Male, as Population Biomarkers for Breast Cancer Mortality

859

Cancer-specific chemoprevention and anti-metastatic potentials of Rheum emodi rhizome ethyl acetate extracts and identification of active principles through HPLC and GC-MS analysis

860

Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma

861

Cancْn following Copenhagen

862

Cancrinite and sodalite formation in the presence of cesium, potassium, magnesium, calcium and strontium in Hanford tank waste simulants

863

864

865

Cancrum oris and noma: some etymological and historical remarks

866

Cancrum oris: its incidence and treatment in Enugu, Nigeria

867

Cancun 2002: The role of nanomaterials in solar energy conversion

868

Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins

869

Candelabra systems and designs

870

Candesartan and heart failure: the allure of CHARM

871

Candesartan Attenuates Ischemic Brain Edema and Protects the Blood–Brain Barrier Integrity from Ischemia/Reperfusion Injury in Rats

872

Candesartan cilexetil and renal hemodynamics in hypertensive patients

873

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension

874

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough

875

Candesartan improves myocardial damage in obese mice with viral myocarditis and induces cardiac adiponectin

876

Candesartan in the prevention of relapsing atrial fibrillation

877

CANDESARTAN TREATMENT RESTORES DIABETES-INDUCED CHANGES IN [CA2+]I TRANSIENTS OF CARDIOMYOCYTES

878

Candesartan-Based Therapy and Risk of Cancer in Patients With Systemic Hypertension (Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Substudy)

879

Candi Sungai Batu (Tapak SB1): Kearifan Tempatan dalam Teknologi Pembuatan Bata dan Seni Bina Candi

880

Candid “confessions” of an editor: prioritizing journal space when increased submissions have led to publication backlog

881

Candid candidate comments: The relationship between residency program selection factors and match list placements from ranked applicants

882

Candid covariance-free incremental principal component analysis

883

Candida Albicans Activated Splenocytes Promote Strong Immune Responses in a Murine Model of Breast Cancer

884

Candida albicans adherence on silicone elastomers: Effect of polymerisation duration and exposure to simulated saliva and nasal secretion

885

Candida albicans Adherence to Glass Ionomer Restorative Dental Material

886

Candida albicans and HTV-1 Infection

887

Candida albicans cell wall comprises a branched β-d-(1→6)-glucan with β-d-(1→3)-side chains Original Research Article

888

Candida albicans depress cardiovascular function of rabbit

889

Candida Albicans detection in pre-malignant and malignant lesions of the oral cavity

890

Candida albicans endophthalmitis after anabolic steroid abuse

891

Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production

892

Candida albicans mannan- and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients

893

Candida albicans Release Intracellular Bacteria When Treated With Amphotericin B

894

Candida albicans Structural and Secreted Proteins Modulate CD4/CD8 Ratio in Tumor Infiltrating Lymphocytes of Spontaneous Adenocarcinoma Bearing Mice

895

Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN - gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages

896

Candida albicansNucleoside-Diphosphate Kinase: Purification and Characterization

897

Candida antarctica lipase A and Pseudomonas stutzeri lipase as a pair of stereocomplementary enzymes for the resolution of 1,2-diarylethanols and 1,2-diarylethanamines

898

Candida antarctica Lipase B Immobilization Onto Hybrid Organic-inorganic Mesoporous Materials

899

Candida antarctica lipase B-catalyzed reactions of β-hydroxy esters: Competition of acylation and hydrolysis

900

Candida antarctica lipase B-catalyzed synthesis of acetamides using [BMIm(PF6)] as a reaction medium

901

Candida antarctica lipase B-catalyzed the unprecedented three-component Hantzsch-type reaction of aldehyde with acetamide and 1,3-dicarbonyl compounds in non-aqueous solvent

902

Candida antarctica lipases acting as versatile catalysts for the synthesis of enantiopure (R)- and (S)-1-(2-phenylthiazol-4-yl)ethanamines

903

Candida Antigen Titer Elevation and Mortality in Burn Patients

904

Candida auris and COVID-19: A health threatening combination

905

Candida auris emergence in the Himalayan foothills: First case report from Uttarakhand, India

906

Candida auris in a tertiary healthcare setting in south India: A case series

907

Candida auris: A New Emerging Fungal Monster

908

Candida auris: outbreak fungal pathogen in COVID-19 pandemic: a systematic review and meta-analysis

909

candida berkh. (1923) species and their important secreted aspartyl proteinases (sap) genes isolated from diabetic patients

910

Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital

911

Candida Carriage Rate and Growth Characteristics of Saliva in Diabetes Mellitus Patients: A Case-Control Study

912

Candida cloacae oxidation of long-chain fatty acids to dioic acids

913

Candida colonisation within a silicone tissue expander

914

Candida Colonization in Low Birth Weight and Very Low Birth Weight Infants in a Neonatal Intensive Care Unit

915

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs

916

Candida Colonization on the Denture of Diabeticand Non-diabetic Patients

917

Candida Colonization on the Denture of Diabeticand Non-diabetic Patients

918

Candida commensalism and virulence: the evolution of phenotypic plasticity

919

Candida dubliniensis: A rare cause of nail infection

920

Candida glabrata oropharyngeal infection in a patient with oral squamous cell carcinoma after COVID-19 infection

921

Candida Glabrata: An emerging threat for the Immunocompromised

922

Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans

923

Candida humilis—dominant species in sourdoughs for the production of durum wheat bran flour bread

924

Candida Infection in a Stent Inserted for Tracheal Stenosis After Heart Lung Transplantation

925

Candida infections among neutropenic patients

926

Candida infections: Novel virulence factors and mechanisms of azole resistance

927

Candida isolates from pregnant women and their antifungal susceptibility in a Malaysian tertiary-care hospital

928

Candida isolation from peritoneal fluid: Its role in the outcome of patients with perforation peritonitis

929

Candida krusei development on turbulent flow regimes: Biofilm formation and efficiency of cleaning and disinfection program Original Research Article

930

Candida laryngitis appearing as carcinoma

931

Candida lung abscesses in a renal transplant recipient

932

Candida parapsilosis as a Potent Biocontrol Agent against Growth and Aflatoxin Production by Aspergillus Species

933

Candida parapsilosis endocarditis 8 months after transient candidemia

934

Candida pericarditis: A rare case report

935

Candida Pericarditis: Clinical Profile and Treatment

936

Candida rugosa lipase immobilized by a specially designed microstructure in the PVA/PTFE composite membrane

937

Candida rugosa lipase Lip1–polyethyleneglycol interaction and the relation with its partition in aqueous two-phase systems

938

Candida rugosa lipase mediated multigram synthesis of acid part of S(+)-atliprofen, a new NSAID and molecular modeling studies aimed at predicting selectivity of the enzyme

939

Candida Rugosa lipase reactions in nonionic w/o-microemulsion with a technical surfactant

940

Candida rugosa lipase-catalyzed enantioselective hydrolysis in organic solvents. Convenient preparation of optically pure 2-hydroxy-2-arylethanephosphonates

941

Candida Rugosa lipase-catalyzed kinetic resolution of β-hydroxy-β-arylpropionates and δ-hydroxy-δ-aryl-β-oxo-pentanoates

942

Candida sepsis in surgery

943

Candida species in cutaneous candidiasis patients in the Guilan province in Iran; identified by PCR-RFLP method.

944

Candida species isolated from clinical samples in a tertiary hospital in Honduras: Where is Candida auris?

945

Candida Species Isolated from Various Clinical Samples and Their Susceptibility Patterns to Antifungals

946

Candida theae sp. nov., a new anamorphic beverage-associated member of the Lodderomyces clade

947

Candida tropicalis chorioamnionitis

948

Candida tropicalis osteomyelitis: Case report and review of literature

949

Candida Urinary Tract Infection Among ICU Patients in Isfahan, Iran

950

Candida utilis assimilates oligomeric sugars in rice straw hydrolysate via the Calcium-Capturing-by-Carbonation (CaCCO) process for glutathione- and cell-biomass production

951

Candidacidal Action of CF66I, an Antifungal Compound Produced by Burkholderia Cepacia

952

Candidacidal activities of the glucose oxidase-mediated lactoperoxidase system

953

Candidacy for active surveillance may be associated with improved functional outcomes after prostatectomy

954

Candidacy for active surveillance may be associated with improved functional outcomes after prostatectomy

955

Candidaemia secondary to intravascular catheter colonisation?

956

Candidaemia secondary to intravascular catheter colonisation? – Authorsʹ reply

957

Candidal Leukoplakia on Patient with Removable Denture

958

Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia

959

Candidate ability and platform choice

960

Candidate AIDS vaccine inspires hope

961

Candidate antiretroviral agents for use in postexposure prophylaxis

962

Candidate biomarker discovery in plasma of juvenile cod (Gadus morhua) exposed to crude North Sea oil, alkyl phenols and polycyclic aromatic hydrocarbons (PAHs)

963

Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens

964

Candidate blanket concepts for a European fusion power plant study

965

Candidate bone-tissue-engineered product based on human-bone-derived cells and polyurethane scaffold

966

Candidate chiral band in 134La Original Research Article

967

Candidate chromosome 1 disease susceptibility genes for Sjogrenʹs syndrome xerostomia are narrowed by novel NOD.B10 congenic mice

968

Candidate Defense Genes from Rice, Barley, and Maize and Their Association with Qualitative and Quantitative Resistance in Rice

969

Candidate eco-labeling and senate campaign contributions

970

Candidate Gender and Electoral Success in Single Transferable Vote Systems

971

Candidate Gene Analysis for Quantitative Traits Using the Transmission Disequilibrium Test: The Example of the Melanocortin 4-Receptor in Pigs

972

Candidate Gene Association Study of Coronary Artery Calcification in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)

973

Candidate gene expression associated with geographical variation in cryoprotective dehydration of Megaphorura arctica

974

Candidate gene marker associations with fatty acid profiles in heavy pigs

975

Candidate gene markers associated with somatotropic axis and milk selection

976

Candidate gene markers for sperm quality and fertility of boar

977

Candidate gene markers involved in San Daniele ham quality

978

Candidate Gene Polymorphism for IL-Ry and ChB6 Genes in the Indigenous Chicken of North Western Himalayan State of Himachal Pradesh, India

979

Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes

980

Candidate gene polymorphisms in solid cancers

981

Candidate Gene Polymorphisms in the Serotonergic Pathway: Influence on Depression Symptomatology in an Elderly Population

982

Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease

983

Candidate genes affecting sheep and goat milk quality

984

Candidate genes and a genome-wide search in Italian families with atopic asthmatic children

985

Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma

986

Candidate genes for behavioural ecology

987

Candidate genes for milk production traits in Portuguese dairy sheep

988

Candidate genes for physical performance in the horse

989

Candidate genes for resistance to Salmonella enteritidis colonization in chickens as detected in a novel genetic cross

990

Candidate genes for resistance to Salmonella enteritidis colonization in chickens as detected in a novel genetic cross

991

Candidate genes in the osteocyte response to mechanical loading in vivo

992

Candidate Genes Polymorphism and Its Association to Prolificacy in Chinese Goats

993

Candidate hypertension-related phenotypes

994

CANDIDATE ISOLATED NEUTRON STARS AND OTHER OPTICALLY BLANK X-RAY FIELDS IDENTIFIED FROM THE ROSAT ALL-SKY AND SLOAN DIGITAL SKY SURVEYS

995

Candidate markers for thromboembolic complications in adult Egyptian patients with β-thalassemia

996

Candidate mechanisms controlling the electrical characteristics of silica/XLPE nanodielectrics

997

Candidate mediators of chondrocyte mechanotransduction via targeted and untargeted metabolomic measurements

998

Candidate Molecular Biomarkers for the Non- Invasive Detection of Colorectal Cancer using Gene Expression Profiling

999

Candidate Notification Scale for Gifted Children in Pre-school Period: Validity and Reliability Studies

1000

Candidate Positioning and Entry in a Political Competition

بازگشت